Invitae
Company

Last deal

$1.15B

Amount

Post-IPO Debt

Stage

05.04.2021

Date

3

all rounds

$2.68B

Total amount

date founded

Financing round

General

About Company
Invitae is a leader in medical genetic testing, improving healthcare globally.

Industry

Sector :

Subsector :

Also Known As

Locus Development Inc

founded date

01.01.2010

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Debt

IPO status

Private

Description

Invitae aggregates medical genetic tests into a single service, offering higher quality, faster turnaround time, and lower prices. Their mission is to make genetic testing affordable and accessible to all. With explosive growth in test volume and revenue, Invitae has helped hundreds of thousands of patients. Their platform combines advanced technologies and genetic expertise to provide personalized genetic information for a wide range of health questions. Invitae fosters a culture of innovation, empowering employees to make decisions and driving towards a future where genetics guide health decisions for everyone.
Contacts
Legal Names

Legal name

Invitae Corporation
Similar Companies
1000
Ambry Genetics

Ambry Genetics

Ambry Genetics offers the most comprehensive genetic testing solutions for 90% of patients in the US.

Sector

Medical Equipment and Services

Subsector

Medical Services

Location

Aliso Viejo, CA, USA

total rounds

1
Genome Medical

Genome Medical

Genome Medical is a national telegenomics technology, services and strategy company.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Health Care, Medical, Biotechnology

Location

South San Francisco, CA, USA

total rounds

7

total raised

$120.72M
Blueprint Genetics

Blueprint Genetics

Blueprint Genetics is a healthcare firm that provides clinical genetic testing to patients using a novel NGS method called OS-Seq:tm:.

Sector

Medical Equipment and Services

Subsector

Medical Services

Keywords

Health Care, Biotechnology, Medical

Location

Helsinki, Finland

total rounds

6

total raised

$21.8M
Good Start Genetics

Good Start Genetics

Good Start Genetics provides pre-pregnancy genetic testing and diagnostics services.

Sector

Medical Equipment and Services

Subsector

Medical Services

Location

Cambridge, MA, USA

total rounds

6

total raised

$60M
M&A Details
1

Transaction name

Acquired by

LabCorp

announced date

24.04.2024

price

$239M

Financials

Funding Rounds
14
3

Number of Funding Rounds

$2.68B

Money Raised

Their latest funding was raised on 05.04.2021. Their latest investor Cowen Investment Management. Their latest round Post-IPO Debt

Date 
Funding Round 
Investors 
Money Raised 
Lead 
05.04.2021
1
$1.15B
20.01.2021
$460M
01.04.2020
$184M
SoftBank

SoftBank

SoftBank is a multinational telecommunications and internet corporation providing various digital products.

Sector

Telecommunications Service Providers

Subsector

Telecommunications Services

Location

Tokyo, Japan

total rounds

4

total raised

$1.99B

count Of Investments

286

count Of Exists

53
Co-Investors
Investors
12
1

Number of lead investors

12

Number of investors

Investor 
Lead 
Round 
Partners 
No
Post-IPO Equity
No
Series F
No
Series F

Cowen Investment Management

Sustainable Private Equity and Credit Investments is a company focused on environmentally-friendly investments in private equity and credit.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services

Location

New York, NY, USA

count Of Investments

53

count Of Exists

9
OrbiMed

OrbiMed

OrbiMed is a healthcare-focused investment firm managing approximately $5 billion in assets.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Venture Capital, Health Care

Location

New York, NY, USA

count Of Investments

561

count Of Exists

82
Three Leaf Ventures

Three Leaf Ventures

Three Leaf Ventures invests in early to late stage technology companies as part of the Broe Group family of companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Denver, CO, USA

count Of Investments

12

count Of Exists

1
Acquisitions
14
Acquiree Name 
Date 
Price 
Acquisition Name 
Ciitizen acquired by Invitae

Ciitizen acquired by Invitae

acquirer

Invitae
Invitae

date

07.09.2021

type

Acquisition

price

$325M
Ciitizen

Ciitizen

Ciitizen aims to empower patients with complete control of their health data.

Sector

Health Care Providers

Subsector

Health Care Services

Keywords

Health Care, Information Technology, Software

Location

Palo Alto, CA, USA

total rounds

4

total raised

$20M
Genosity acquired by Invitae

Genosity acquired by Invitae

acquirer

Invitae
Invitae

date

05.04.2021

type

Acquisition

price

$200M
Genosity

Genosity

Genosity is a biotechnology company that provides tools and services for clinical research applications of genomics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Iselin, Woodbridge Township, NJ, USA
One Codex acquired by Invitae

One Codex acquired by Invitae

acquirer

Invitae
Invitae

date

19.02.2021

type

Acquisition
One Codex

One Codex

One Codex is a bioinformatics platform for applied microbial genomics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

San Francisco, CA, USA

total rounds

3

total raised

$120K

People

Founders
5

Sean George

organization founded

1

Sean George

Mat Falkowski
Mat Falkowski

Mat Falkowski

Serial Enterpreneur (1 IPO, 1 Acquisition)

current job

Circularis Biotechnologies
Circularis Biotechnologies

organization founded

1

Mat Falkowski

Randy Scott
Randy Scott

Randy Scott

current job

BridgeBio
BridgeBio

count Of Investments

1

Randy Scott

Michele Cargill
Michele Cargill

Michele Cargill

Michele has more than 17 years of experience as a human geneticist in both industry and academia, with a primary interest in discovering the genes that contribute to human disease and translating that information for patients and medical care professionals. She trained under the David Botstein at Stanford Medical School, where she earned her doctorate in genetics, and under Eric Lander at the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, where she completed her postdoctoral training. Prior to co-founding Locus Development, Dr. Cargill was the vice president of genetics at Navigenics and the associate director of genomic collaborations at Affymetrix. She also served as a senior staff scientist at Celera Diagnostics and as the scientific program manager at Celera Genomics.

current job

Invitae
Invitae

organization founded

1

Michele Cargill

Employee Profiles
284
Kristine Ashcraft

Kristine Ashcraft

Medical Affairs Director, Pharmacogenomics

Aaron Campbell

Clinical laboratory manager

Shivam Vora

Product design lead, user experience strategy and research

Aaron Small

Aaron Small

Internal Cloud Engineering Lead

Matthew Cloney

Data engineer

Turgut Dogruluk

Clinical genomics scientist

Bobby Singfield

Regional manager oncology and women's health

Vivian Kam

Head of engineering, scale and quality

Activity

Recent News
9
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month